The quarter is likely to reflect mixed implications from the US-Iran conflict, as higher freight and raw material costs could ...

Pharma sector may see a 7 per cent Y-o-Y growth in reported sales and a 1 per cent increase in Ebitda, led by steady ex-gRevlimid US sales, healthy domestic growth, and favourable forex movements ...

The Indian pharmaceutical landscape is evolving as local generics prepare to take over the GLP-1 market following the patent expiry of Novo Nordisk's semaglutide. The shift from brand dominance to ...

Get all latest & breaking news on Pharma Sector. Watch videos, top stories and articles on Pharma Sector at moneycontrol.com.

Lupin announced the launch of Dapagliflozin Tablets in strengths of 5 mg and 10 mg in the United States, following approval of its abbreviated new drug application (ANDA) by the U.S. Food and Drug ...

Among the large-cap companies, the brokerage expects Lupin to post a decent showing, while India-focused companies like ...

A wave of affordable generic versions of Ozempic and Wegovy (semaglutide) has rapidly captured around 20% of the nearly Rs ...

Stocks like Mahindra and Mahindra, Larsen & Toubro, Swiggy, Enviro Infra Engineers, Advait Energy Transitions, Mahanagar Gas, Krishna Defence and Allied Industries, Lupin, AstraZeneca Pharma India, ...

Lupin Limited announced the launch of Dapagliflozin Tablets in the United States in strengths of 5 mg and 10 mg. The launch ...

MUMBAI, India and LONDON and ROME and ZUG, Switzerland, April 2, 2026 /CNW/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) announced the ...

The book also refreshingly reveals the significant role played by the women of founder Desh Bandhu Gupta’s family in shaping ...

GKIDS will be screening Lupin the IIIRD: The Immortal Bloodline from January 4 – 6, 2026 in select US theaters The film marks the 13th entry in the franchise, and the final entry in Takeshi Koike’s ...